Long-term exposure to fine particle elemental components and lung cancer incidence in the ELAPSE pooled cohort.

Hvidtfeldt, Ulla ArthurChen, JieAndersen, Zorana JovanovicAtkinson, RichardBauwelinck, MariskaBellander, TomBrandt, JørgenBrunekreef, BertCesaroni, GiuliaConcin, HansFecht, DanielaForastiere, Francescovan Gils, Carla HGulliver, JohnHertel, OleHoek, GerardHoffmann, Barbarade Hoogh, KeesJanssen, NicoleJørgensen, Jeanette ThermingKatsouyanni, KleaJöckel, Karl-HeinzKetzel, MatthiasKlompmaker, Jochem OLang, AloisLeander, KarinLiu, ShuoLjungman, Petter L SMagnusson, Patrik K EMehta, Amar JayantNagel, GabrieleOftedal, BentePershagen, GöranPeter, Raphael SimonPeters, AnnetteRenzi, MatteoRizzuto, DeboraRodopoulou, SophiaSamoli, EvangeliaSchwarze, Per EverhardSeveri, GianlucaSigsgaard, TorbenStafoggia, MassimoStrak, MaciejVienneau, DanielleWeinmayr, GudrunWolf, KathrinRaaschou-Nielsen, Ole2020-12-302020-12-302020-12-023327846910.1016/j.envres.2020.110568http://hdl.handle.net/10029/624601An association between long-term exposure to fine particulate matter (PM2.5) and lung cancer has been established in previous studies. PM2.5 is a complex mixture of chemical components from various sources and little is known about whether certain components contribute specifically to the associated lung cancer risk. The present study builds on recent findings from the "Effects of Low-level Air Pollution: A Study in Europe" (ELAPSE) collaboration and addresses the potential association between specific elemental components of PM2.5 and lung cancer incidence.enCopyright © 2020 Elsevier Inc. All rights reserved.Air pollutionElemental componentsFine particulate matterLung cancer incidencePooled cohortLong-term exposure to fine particle elemental components and lung cancer incidence in the ELAPSE pooled cohort.Article1096-0953Environ Res 2021; 193:110568